Freedom Leaf's Tierra Science Global Launches National Tour at American Naturopathic Medical Association Conference 2018.

Las Vegas, NV -- August 16, 2018 -- Freedom Leaf, Inc. (OTCQB: FRLF), a Company dedicated to health and wellness products derived from legal Hemp and comprised of a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies, announces today that it's wholly owned subsidiary, Tierra Science Global, is launching a national tour and global webinar series for its affiliate platform beginning with presence as a vendor at the American Naturopathic Medical Association Conference August 24-26, 2018 (www.anma.org).

Tierra's kickoff business briefing was held on Saturday, August 11, 2018 in Las Vegas with guests from around the world. Attendees included top influencers in Direct Marketing and key influencers from the Online/Social Marketing Industries. Product line samples and overall business model were shared with many who will become key leaders in marketing Tierra's super-affiliate program which goes live later this month.

Tierra's event included presentations by founders Mark Rosales and Marc Vitorillo, Dr. Naina Sachdev of NAINAMD, CBD/Hemp expert Dr. Rick Potts of IRIECBD and Freedom Leaf Officers, Raymond Medeiros and Clifford Perry, who were duly impressed with the new company's objectives.

CEO Clifford Perry states, "The event was a big success. We were very impressed by the platform and team assembled by Tierra and are thrilled with the potential here. We are positioned with a terrific opportunity for affiliate marketers from around the world and supported by a winning online and social marketing strategy toward record setting revenues for Tierra."

Tierra has already achieved in excess of $500,000 in revenues from January to June of 2018 with its existing product line, which include premium supplements focused on increase of mental stamina, athletic performance, benefits to the heart and protection from harmful effects of Electromagnetic fields produced by cell phones, laptops, gaming consoles and other devices.

As previously announced, Freedom Leaf will take the brand and potential revenues one significant step further by manufacturing a number of unique Full Spectrum Hemp/CBD oil products.

The CBD Industry grew by nearly 40% in 2017, which marks the first year that Hemp-derived CBD products, like the full spectrum CBD manufactured by Freedom Leaf, outpaced sales for marijuana-derived CBD products. According to New Frontier Data, Surging demand is expected to result in 2018 being a break-out year for CBD, with the total market expanding to more than $500 million in sales. The report projects that the CBD industry will grow to $1.2 billion by 2020, and nearly $2 billion by 2022. Execs are confident that Freedom Leaf, Inc.'s full spectrum hemp lines, including IrieCBD and hempology, will capture a significant market share alongside industry growth.

Listen to Freedom Leaf, Inc. CEO, Clifford J Perry, on a recent Stock Day and Uptick Newswire radio show https://upticknewswire.com/featured-interview-ceo-clifford-perry-of-freedom-leaf-inc-otcpink-frlf/

 

Visit the Freedom Leaf Inc., message board on: https://investorshangout.com/. 

 

About Freedom Leaf, Inc.(R)

Freedom Leaf, Inc. (OTCQBFRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf, Inc. is a fully-reporting and audited publicly-traded company under the symbol (otcqb:FRLF). Freedom Leaf, Inc. has been a leading go-to resource in the cannabis, medical marijuana and industrial hemp industries since 2014, founded by professionals with over 200 years combined experience in marijuana legalization advocacy. FRLF is building a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry. 

FRLF's large portfolio of acquisitions and properties includes: our recently acquired full spectrum hemp oil product line - Irie CBD; our wholly-owned hemp extraction division - Leafceuticals, Inc.; our exclusive health and wellness full spectrum hemp oil brand - Hempology, our just-acquired indoor hemp greenhouse in Valencia, Spain for the cultivation of Hemp; our hemp-based rolling paper company - Plants to Paper; two of the largest Spanish-speaking cannabis web portals in the world - LaMarihuana.com and Marihuana-Medicinal.com, and of course our flagship publication - Freedom Leaf Magazine. 

Utilizing these mergers and acquisitions, Freedom Leaf, Inc. is continually building a solid foundation for our vertically-integrated hemp company to maximize both revenue growth, and net profit, which will increase our shareholders value. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp CBD, which allows dramatically lower production costs for our wholly-owned CBD product lines, thereby generating more revenue for each product sold. We formulate and manufacture the majority of our products in our own in-house formulation centers, also greatly reducing our costs and increasing revenue. In addition, our extensive domestic and international media companies ensure we can continuously direct traffic to our many ecommerce sites and nationwide retail locations. Freedom Leaf, Inc. also sells licenses to use the Freedom Leaf brand in different countries and states across the globe. We have entered into three license agreements: for Spain and Portugal, for The Netherlands, and for Southern California. 

Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana or related products

All of our European activities are in full compliance with relevant EU laws.

Investor relations information can be found on

the FreedomLeafInc.comcompany website.

 

Safe Harbor Statement

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. All statements other than statements of historical facts included in this news release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other media and cannabis/hemp-related products and services; the effects of changes in laws governing the cannabis and hemp industries; our ability to successfully develop and sell new products and services; our success establishing and maintaining industry relationships, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 

 

Contact: 
Raymond Medeiros 
PR and Business Development Director 
Phone: 415-601-1974 
ray@freedomleaf.com 
Freedom Leaf, Inc.